Trade Summary

5 months ago, Tang Kevin, serving as Dir at Aurinia Pharmaceuticals Inc. (AUPH), purchased 1,300,000 shares at $10.45 per share, for a total transaction value of $13,590,000.00. Following this transaction, Tang Kevin now holds 11,329,500 shares of AUPH.

This purchase represents a 13.00% increase in Tang Kevin's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, August 1, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, August 5, 2025, 4 days after the trade was made.

Aurinia Pharmaceuticals Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.